TWI252912B - Histological processing of tissue and other material - Google Patents
Histological processing of tissue and other material Download PDFInfo
- Publication number
- TWI252912B TWI252912B TW089102812A TW89102812A TWI252912B TW I252912 B TWI252912 B TW I252912B TW 089102812 A TW089102812 A TW 089102812A TW 89102812 A TW89102812 A TW 89102812A TW I252912 B TWI252912 B TW I252912B
- Authority
- TW
- Taiwan
- Prior art keywords
- dye
- embedding
- sample
- matrix
- tissue
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims description 10
- 238000012735 histological processing Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000011159 matrix material Substances 0.000 claims description 34
- 238000004043 dyeing Methods 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 6
- 238000010186 staining Methods 0.000 abstract description 2
- 239000012192 staining solution Substances 0.000 abstract 2
- 239000000975 dye Substances 0.000 description 34
- 239000000243 solution Substances 0.000 description 19
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- 239000012188 paraffin wax Substances 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- AHWMWMNEYBHQNL-UHFFFAOYSA-N 4-(naphthalen-1-yldiazenyl)benzene-1,3-diamine Chemical group NC1=CC(N)=CC=C1N=NC1=CC=CC2=CC=CC=C12 AHWMWMNEYBHQNL-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 229920003319 Araldite® Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003535 biological staining Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 150000002013 dioxins Chemical class 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- VGVYRHYDNGFIGF-UHFFFAOYSA-N fumarin Chemical compound OC=1OC2=CC=CC=C2C(=O)C=1C(CC(=O)C)C1=CC=CO1 VGVYRHYDNGFIGF-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine acetate Natural products C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/36—Embedding or analogous mounting of samples
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Microscoopes, Condenser (AREA)
Abstract
Description
1252912 五、發明說明^- 發明背景1252912 V. INSTRUCTIONS ^- BACKGROUND OF THE INVENTION
本發明 法 係有關於一種處理組織樣品以用於顯像的 方 a 鏡檢, 把樣品 的產生 在 可作為 樣品堅 用。後 漸置換 精及二 之後, 使其固 並且以 block) 同物質 有機的 進行― ’而將 這個方 保存樣 固並增 續的滲 ’以移 甲苯。 接著是 化。此 額外的 。微波 的滲透 於可見 組織樣 系列的 樣品包 法中, 品 5 避 加其通 透步驟 除樣品 在習知 以融化 硬化的 石蠟圍 爐已使 光及電子顯微鏡檢兩者的穿透式顯」 品及其他物質的製備,正常地是藉, 化學處理,導致一固體基塊(bl〇ck) 埋於其中。 組織首先以福馬林、 免自溶(自我分解)的 透性,藉此增強後續 是設計為藉由以增加 中所有的水分,所使 的光學顯微鏡檢的例 的石蠟處理,然後將 、滲透的組織接著放 繞’以產生一組織基 用在組織學的實驗室 戊二醛、或其〈 材料固定,使^ 溶液的滲透作 濃度的溶劑而〗 用的溶劑例如; 子中,滲透作] 樣品冷卻至室 置在一模子中 塊(t i s s u e 中’用以加迷;The method of the present invention relates to a square a microscopic examination for processing a tissue sample for visualization, and the production of the sample can be used as a sample. After the gradual replacement of the fine and the second, it is solidified and carried out in block organic matter with the substance - and the side is preserved and continuously osmized to shift toluene. Then it is. This extra. The microwave penetrates into the sample-package method of the visible tissue-like series, and the product 5 avoids the permeation step. In addition to the sample, in the conventional melting-hardened paraffin furnace, the light and electron microscopy have been used to penetrate the product. And the preparation of other materials, normally borrowed, chemically treated, resulting in a solid block (bl〇ck) buried therein. The tissue is first treated with fumarin, self-dissolving (self-decomposing) permeability, thereby enhancing the subsequent design of the paraffin by designing an optical microscopy by increasing all the moisture, and then, infiltrating The tissue is then placed around to produce a tissue-based glutaraldehyde used in the histological laboratory, or a solvent used to immobilize the solution to make the solution osmotic as a solvent, for example, in a submerged sample. Cooling to the chamber in a mold block (in the tissue 'to add to the fan;
除了石蠟外,塑膠也廣 膠可以是甲基丙烯酸酯、環 但無論如何,組織是以大約 來處理。在組織中的水分是 體聚合物取代。聚合物之現 法而使其固化(聚合),包括 泛地使用於產生組織基塊。塑 氧樹脂聚合物或相關的材料, 相同於在石蠟中所使用的方法 以有機溶劑取代,接著再以液 合的别驅物成份,藉由各種方 曝露於紫外光、熱之下,或添In addition to paraffin, the plastic can also be methacrylate, but in any case, the tissue is treated as approximately. The moisture in the tissue is replaced by a bulk polymer. The polymer is then cured (polymerized), including in the general use of the resulting building blocks. The plastic oxy-resin polymer or related material is replaced by an organic solvent in the same manner as in paraffin, followed by liquefied other components, exposed to ultraviolet light, heat, or added by various means.
第4頁 1252912 五、發明說明(4) 處理組織,此物質在分子的層次上與組織結合。 此處所使用的名詞’’極性π及’’親水性’’是同義地指強水 溶性的化學物質,而名詞π非極性”及’,厭水性”是指差水溶 性的化學物質,但卻是容易地溶於有機溶劑中,以及溶於 脂肪或脂質中。 此處所使用的名詞”不透明作用劑’’是指加到包埋及渗 透基質的物質,以產生非常高的吸光值,其抑制組織的^ 像,導源於在基塊中超過數微米的深度。不透明作用劑的Page 4 1252912 V. INSTRUCTIONS (4) To deal with tissue, this substance binds to tissue at the molecular level. The term ''polar π' and ''hydrophilic'' as used herein is synonymously referring to a chemical substance that is highly water-soluble, while the noun π is non-polar and ', and anaerobic' refers to a chemical substance that is poorly water-soluble, but It is easily soluble in organic solvents and soluble in fats or lipids. The term "opaque agent" as used herein refers to a substance that is added to the embedded and infiltrated matrix to produce a very high absorbance which inhibits the image of the tissue, resulting in a depth exceeding a few microns in the matrix. Opaque agent
一個例子是Fat Brown RR(Solvent Brown 1 ;sigma Chemicals, St. Louis, MO) 〇 非極性滲透及包埋物質的使用(例如環氧樹脂或石 蠟,其中極性染劑顯示很少的溶解度),伴隨以極性染劑 將組織染色,使得極性染劑分配至組織中,以將親水性的 成份(例如蛋白質)染色,並且阻止染劑進入周圍的基質, 以提升高度的對比影像。 另外,也可使用非極性、脂溶性(也就是厭水性)的染 劑,以將組織中富含脂肪的結構(例如細胞膜)染色。在這 樣的狀況中,使用極性的包埋物質,例如乙二醇甲基丙烯An example is Fat Brown RR (Solvent Brown 1 ; sigma Chemicals, St. Louis, MO) 〇 use of non-polar osmotic and embedding materials (eg epoxy or paraffin, where polar dyes show little solubility), with The tissue is stained with a polar dye to distribute the polar dye into the tissue to stain the hydrophilic component (eg, protein) and prevent the dye from entering the surrounding matrix to enhance the height of the contrast image. Alternatively, non-polar, fat-soluble (i.e., water-repellent) dyes can be used to stain the fat-rich structures (e.g., cell membranes) in the tissue. In such a situation, polar embedding materials such as ethylene glycol methacryl are used.
酸 S旨(Polysciences, Inc· Warrington,PA),以避免非 極性染劑從組織擴散到包埋基質,藉此增強組織影像中的 對比。 對於本發明的重點之一項主要原因,是在整體染色之 後’以及在一些類型的顯微鏡檢(包括基塊面顯微鏡檢)顯 像之前’此滲透及包埋基質並沒有移除。因此,使用這些 1252912 五、發明說明(5) 技術對於高對比影像的產生是重要 身的影像訊號會被消除,也就是,才样^源於包埋物質本 高對比是基本的。因為選擇相對’叩及包埋基質間的 的包埋基質使用(例如,乙二醇甲7性*的染劑,以與極性 (固體的聚乙二醇;Union CarbideAc丙烯酸5旨及Carbowax CT)),因此,預先整體染色之處之二Danbury 進入周圍基質。不含染劑的包埋基質=木=彳可避免 的組織及周圍基質間之改善的對比。、、、、寺,導致在染色 本發明的其他特徵及優,點,將從 明以及申請專利範圍中,將變得顯而 車又乜貝鈿例之現 發明詳述 ° 任何染劑在一給定的基質中之 定的基質經驗地決定。對於許多毕=’可對於任何給 資料(例如,Merck Index)而測定Ί解谷声解度可使用參考 U/v ;1。0克/100 毫升,0%)、或升:示克如 或重量克分子濃度。例如,¥高\表氏不/^積克分子濃度 7 一甲基胺基-2-甲基吩嗪氫氯化物), 4,,⑩升)的溶解度;在無水酒精中18;= 度;在乙二醇中3. 0%的溶解度;以及在二甲苯中 2 溶解度(Merck Index,上文)。另一種染劑,曙紅1 ^ 下列的溶解度:在水中44.0% ;在酒精中2 〇% ;在乙二〃有 乙醚(Cellosolve)中 25· 0% ;在乙二醇中27· 5% ;以一 甲苯中少於0.1%(Electr〇n Micr〇sc〇py SeieneesFQft 一Acid S (Polysciences, Inc. Warrington, PA) to avoid diffusion of non-polar dyes from the tissue to the embedded matrix, thereby enhancing contrast in tissue images. One of the main reasons for the focus of the present invention is that the infiltrated and embedded matrix is not removed after the overall staining' and before some types of microscopy (including basal surface microscopy) imaging. Therefore, the use of these 1252912 V, invention description (5) technology is important for the production of high-contrast images, the image signal will be eliminated, that is, the source is derived from the embedding material. High contrast is essential. Because the choice is based on the use of the embedding matrix between the 叩 and the embedded matrix (for example, the dye of ethylene glycol 7*, with polarity (solid polyethylene glycol; Union Carbide Ac Acrylic 5 and Carbowax CT) ), therefore, the first integral dyeing place Danbury enters the surrounding matrix. Embedding matrix without dyeing agent = improved comparison between wood and 彳 avoidable tissue and surrounding matrix. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, The substrate in a given matrix is empirically determined. For many times = ' can be used for any given data (for example, Merck Index) to determine the resolution of the solution to the valley can be used to reference U / v; 1.0 g / 100 ml, 0%), or liter: show grams or weight Molecular concentration. For example, the solubility of ¥高\表氏不/^克克浓度7-methylamino-2-methylphenazine hydrochloride, 4, 10 liters; 18% in anhydrous alcohol; 3.0% solubility in ethylene glycol; and 2 solubility in xylene (Merck Index, supra). Another dye, Eosin 1 ^ The following solubility: 44.0% in water; 2% in alcohol; 25.0% in ethyl ether (Cellosolve); 27.5% in ethylene glycol; Less than 0.1% in a toluene (Electr〇n Micr〇sc〇py SeieneesFQft one
12529121252912
五、發明說明(6)V. Description of invention (6)
Washington,PA,1 99 9 目錄)。 一本發明的方法之最重要的元素是,在包埋溶液中 的溶解度要小於在染色溶液中染劑的溶解度。相 1 色溶液中染劑的溶解度,在包埋溶液中愈低百分比的溶ς 度,就有愈高的對比。較佳地,此百分比是小於5〇%,/更 佳地小於20% ’以及最佳地小於1〇%或甚至2%。 °Washington, PA, 1 99 9 Table of Contents). The most important element of a method of the invention is that the solubility in the embedding solution is less than the solubility of the dye in the dye solution. The solubility of the dye in the phase 1 solution, the lower the percentage of solubility in the embedding solution, the higher the contrast. Preferably, this percentage is less than 5%, / more preferably less than 20% ' and optimally less than 1% or even 2%. °
表1包含一系列與極性染料溶液相容的染劑,以及適 用於本發明之相關的非極性包埋基質。表1也包含一系列 與染脂質之尼羅河紅(N i 1 e Red)相容之極性包埋基質。這 些名冊是用於舉例說明的目的,而非用以限制本發明。應 了解的是’其他的染劑,例如表列在C ο η η,H. J ·,,生物性 染色n(第9版,The Williams and Wilkens Co., B a 11 i m o r e 1 9 7 7 )的染劑,也可與一種或多種以下所列的 包埋基質相容。相似地,其他的包埋基質也可與,例如表 1或Conn(上文)所提供之染劑相容。 表1Table 1 contains a series of dyes compatible with polar dye solutions, as well as related non-polar embedded matrices suitable for use in the present invention. Table 1 also contains a series of polar embedding matrices compatible with lipid-coated N i 1 e Red. These lists are for illustrative purposes and are not intended to limit the invention. It should be understood that 'other dyes, such as listed in C ο η η, H. J ·,, biological staining n (9th edition, The Williams and Wilkens Co., B a 11 imore 1 9 7 7 ) The dye may also be compatible with one or more of the embedded substrates listed below. Similarly, other embedding matrices may be compatible with, for example, the dyes provided in Table 1 or Conn (above). Table 1
與極性染色溶液相非極性之包埋基質 容之染劑 與非極性染色溶液極性之包埋基質 相容之染劑 球化丙鍵 石螺· 溴化乙键 Araldite 吖啶權 Epon 曙紅Y Spurr 德州紅 火棉(Cellodin) DAPI 紐波特綠 吩綠TMFL 尼羅河紅 Carbowax 乙二醇 f基丙烯駿 洋莱 動物明膠 OTCIncompatible with polar dyeing solution, non-polar embedded matrix dyeing agent compatible with non-polar dyeing solution polar embedded matrix spheroidized spheroidal snail · brominated ethyl bond Araldite acridine right Epon blush Y Spurr Texas Red Fire Cotton (Cellodin) DAPI Newport Green Green TMFL Nile Red Carbowax Ethylene Glycol F-Based Acrylic Jun Yang Lai Animal Gelatin OTC
實施例Example
第9頁 1252912 五、發明說明(7) 實施例1 : 一組織製備物,其中在樣品中的蛋白質要整體染色, 包含下列的成份,其中,染劑是高水溶性,以及包埋基質 是厭水性的: 染劑:2%曙紅Y螢光染料之水溶液(Si gma Chemicals, St· Louis,MO)。包埋/滲透基質:以石蠟為基底的包埋 基質(Surgipath Medical Industries Inc·, Richmond IL)。不透明作用劑··飽和的Fat Brown RR(Solvent Brown 1 ; Sigma Chemicals, St. Louis, MO) 〇Page 9 1252912 V. INSTRUCTIONS (7) Example 1 : A tissue preparation in which the protein in the sample is to be dyed as a whole, comprising the following ingredients, wherein the dye is highly water soluble and the embedded matrix is boring Aqueous: Dye: 2% aqueous solution of Eosin Y fluorescent dye (Si gma Chemicals, St. Louis, MO). Embedding/infiltrating matrix: a paraffin-based embedding matrix (Surgipath Medical Industries Inc., Richmond IL). Opaque Agent · Saturated Fat Brown RR (Solvent Brown 1 ; Sigma Chemicals, St. Louis, MO) 〇
不透明的基質是藉由將過量的不透明作用劑,在適度 的攪拌下,溶解至融熔的石蠟中而製備。在持續加熱的環 境下,將混合物靜置1小時,然後倒出。組織樣品藉由浸 沒在曙紅Y溶液中而染色,後續經由分級的酒精及二曱笨 處理,然後滲透並包埋至不透明的基質中。組織基塊在基 塊面顯微鏡上顯像。 實施例2 :An opaque substrate is prepared by dissolving an excess of opaque agent in a molten paraffin with moderate agitation. The mixture was allowed to stand for 1 hour in a continuously heated environment and then poured out. Tissue samples were stained by immersion in Eosin Y solution, subsequently treated with graded alcohol and dioxins, then infiltrated and embedded in an opaque matrix. The tissue blocks were visualized on a block surface microscope. Example 2:
一組織製備物,其中在樣品中的核酸要染色,其中, 染劑是高水溶性,以及包埋基質是厭水性的,包含下列的 成份: 染劑:1%碘化丙錠染料之水溶液(Sigma ChemieaU, St. Louis, M0)。包埋/滲透基質:Epon環氧樹脂基質 (Polysciences, Inc. Warrington, PA) °A tissue preparation in which a nucleic acid in a sample is to be dyed, wherein the dye is highly water-soluble, and the embedding substrate is water-repellent, comprising the following components: Dye: 1% aqueous solution of propidium iodide dye ( Sigma ChemieaU, St. Louis, M0). Embedding/Infiltration Matrix: Epon Epoxy Resin Matrix (Polysciences, Inc. Warrington, PA) °
Epon是根據製造手冊而製備。組織樣品藉由浸沒在碘 化丙錠溶液中而染色,後續經由分級的酒精及二甲苯處Epon is prepared according to the manufacturing manual. Tissue samples were stained by immersion in a propidium iodide solution, followed by fractionated alcohol and xylene
第10頁 1252912Page 10 1252912
理,然後滲透並包埋至環氧樹脂基質中。組織基塊在 顯影顯微鏡上顯像。 實施例3 ·· 一組織製備方法,其中在樣品中的中性脂質要染色, 包含下列的成份’其中,染劑是低水溶性,以及包埋基質 是高水溶性的: 、 染劑:1%尼羅河紅染料之溶液(M〇lecular Pr〇bes, Eugene,OR) ’溶解於2—甲氧基乙醇中。包埋/滲透基質: 完全濃度的乙二醇甲基丙烯酸酯催化之滲透樹脂Then, it is infiltrated and embedded in an epoxy resin matrix. The tissue blocks were visualized on a development microscope. Embodiment 3 A tissue preparation method in which a neutral lipid in a sample is dyed, comprising the following components: wherein the dye is low in water solubility, and the embedded matrix is highly water-soluble: dyeing agent: 1 % Nile red dye solution (M〇lecular Pr〇bes, Eugene, OR) 'dissolved in 2-methoxyethanol. Embedding/infiltrating matrix: complete concentration of ethylene glycol methacrylate catalyzed infiltration resin
(Polysciences, lnc· Warrington, PA)。 將組織樣品置於個別1 〇毫升小瓶中的染料溶液,並且 旋轉混合24小時。然後將滲透及染色的樣品轉移至2毫升 具有過量配方的包埋膠囊,旋轉混合24小時,以5, 0 00轉/ 分鐘(r pm )離心1 0分鐘,使樣品易於沈澱,並使其在室溫 下聚合(大約1小時)。基塊在表面顯影顯微鏡上顯像。 參考文獻(Polysciences, lnc· Warrington, PA). The tissue samples were placed in a dye solution in individual 1 〇 ml vials and spun for 24 hours. The infiltrated and stained samples were then transferred to 2 ml of embedded capsules with excess formulation, vortexed for 24 hours, centrifuged at 5,00 rpm (r pm ) for 10 minutes to allow the sample to precipitate easily and allow Polymerization at room temperature (about 1 hour). The blocks were visualized on a surface development microscope. references
組織學技術的實驗室方法:p r e p a r e d b y t h e A r m e d Forces Institute of Pathology· ed· Prophet, Ε·Β·, Arrington J.B.,Sob i n L.H. American Registry of Pathology, Washington, D.C·, 1992 。Laboratory methods for histological techniques: p r e p a r e d b y t h e A r m e d Forces Institute of Pathology· ed· Prophet, Ε·Β·, Arrington J.B., Sob i n L.H. American Registry of Pathology, Washington, D.C., 1992.
Carson, F.L·組織學技術:A self-instructionalCarson, F.L. Histology: A self-instructional
Text. ASCP Press, American Society of Pathologists, Chicago, 1990 o S h e e h a n,D · C ·,H r a p c h a k,B · B ·組織學技術的理論Text. ASCP Press, American Society of Pathologists, Chicago, 1990 o S h e e h a n, D · C ·, H r a p c h a k, B · B · Theory of histological techniques
1252912 五、發明說明(9) 與實用,第2版,Battelle Press, Columbus 0H, 1980 。 美國專利第4,9 6 0,3 3 0號,’’顯像記錄裝置”。 所有此處所提到的專利及公開文件都併入此處作為參考文1252912 V. INSTRUCTIONS (9) AND PRACTICE, 2nd ed., Battelle Press, Columbus 0H, 1980. U.S. Patent No. 4,9, 60, 3, 3, ''Development Recording Apparatus'. All patents and publications mentioned herein are incorporated herein by reference.
1084-3013-PFl.ptc 第1頁 1252912 五、發明說明(2) =學催化劑。塑膠操作方法已為光學及電子顯微鏡檢所 上切:於:i:ί中的每一種,含有組織之基塊在切片機 心i放鏡檢的例子中,切片是在玻璃载片上 Η又栗並放置。一旦固定.韵 劑染色,這些染劑標示特— ,此切片接著就以各種染 質等),式去另外,、、、_疋的、、、田胞部位(例如,核酸、脂 法。 $ ’处理這些切片以用於免疫組織化學 另外,這些方法士 ρ道 在進行渗透及包埋之前,體㈣㈣染色’其中’ 塊的切割面本身以一i稱X:穿透式顯微鏡檢’或是基 像。在後者,包括塊面顯微鏡檢的方式而顯 色的樣品,後續地藉由1、二)冷已經以螢光染劑整體染 常是-塑膠聚合物,4^而)多透並且包埋’此基質通 得組織的影像抑制,重的不透明或經其他處理’使 度。這導致-薄的、在基塊中超過數微米的深 生,極類似習知玻璃^ section)"的產 t 發明摘述 載片固定的組織切片。 本發明的特徼杲一絲 法,包括下列步種用於整體染色及包埋樣品之方 液中,其可逆地社人至二樣品浸沒到含有染劑的染色溶 。至该樣品的一成份;以及(b)將樣品1084-3013-PFl.ptc Page 1 1252912 V. INSTRUCTIONS (2) = Learning catalyst. The plastic operation method has been cut by the optical and electronic microscopy: in each of the following: i: ί, the base block containing the tissue is placed in the microscopic examination of the slicer, and the slice is smashed on the glass slide. Place. Once fixed, rhyme dyeing, these dyes are marked with special, and the slices are then subjected to various dyes, etc., to the other, (,, _ 疋, 、, TP fields (eg, nucleic acid, lipid method. 'Processing these sections for immunohistochemistry. In addition, these methods are used to infiltrate and embed, and the body (4) (4) stains 'where the 'cut surface of the block itself is called an X: transmissive microscopy' or Base image. In the latter case, a sample that is developed by means of block microscopic examination, followed by 1 and 2) cold has been dyed with a fluorescent dye as a whole - a plastic polymer, 4^) Embedding 'this matrix is ubiquitous in image suppression, heavy opacity or other treatments' degree. This results in a thin, deeper than a few micrometers in the matrix, which is very similar to the conventional glass. The special filament method of the present invention comprises the following steps for the overall dyeing and embedding of a sample in a solution which is reversibly immersed in a dye solution containing a dye. To a component of the sample; and (b) to sample
案號 89102812Case No. 89102812
1252912 五、發明說明(3) 包埋到一包埋基質中,其中該染劑在該包埋基質中的溶解 度不超過該染劑於該染色溶液中之5〇%。 較佳地,包埋基質也是滲透物質,並且可包括一不透 明物質。較佳地,染劑在包埋基質中之溶解度不超過其溶 解在染色溶液中之2 0 % ;更佳地,染劑在包埋基質中之、、容 解度不超過其在染色溶液中之10%或甚至2%。在其他較^ 具體實施例中,樣品是生物組織樣品,例如,由人類屍 所得到的樣品,或從切片檢查的病患所得到的樣品。_ 此處所使用的名詞”樣品”是指要毕色 其他物質。在染色之前,樣心:::+包埋的組織或 =的厚度是大於200微米,並且可大於丨公楚、丨公分或更篆 此處所使用的名詞”固定”是指以化 品,其可保存、硬化及通透此樣品。☆液處理組織樣 此處所使用的名詞”滲透"是指以一/ 體處理組織,其可穿透組織至分子声 f 一糸列的液 體,以使得樣品堅硬。 θ 然後轉形成固1252912 V. INSTRUCTION DESCRIPTION (3) Embedding into an embedded matrix wherein the solubility of the dye in the embedded matrix does not exceed 5% of the dye in the dyeing solution. Preferably, the embedding substrate is also a permeable material and may comprise an opaque substance. Preferably, the solubility of the dye in the embedding matrix is not more than 20% of that dissolved in the dyeing solution; more preferably, the dyeing agent is in the embedding matrix, and the degree of disproportion does not exceed that in the dyeing solution. 10% or even 2%. In other more specific embodiments, the sample is a biological tissue sample, such as a sample obtained from a human cadaver, or a sample obtained from a biopsy patient. _ The term "sample" as used herein refers to other substances that are to be colored. Prior to dyeing, the core:::+embedded tissue or = thickness is greater than 200 microns, and may be greater than the gong, Chu, or 篆. The term "fixed" as used herein refers to a chemical product. It can be stored, hardened and penetrated. ☆Liquid treatment of tissue samples The term "infiltration" as used herein refers to the treatment of tissue in one body, which can penetrate the liquid to the molecular sound f to make the sample hard.
此處所使用的名詞”句 S 模子中,並以一物質J二二指將渗透的組織包含在一 〜貝玉衣繞(通常相团於、’灸、签、 ^ 化以形成一包裝基塊。包埋物質因此、於1透日物質),然後硬 角色,並且使得切割步驟變得容易刀碉提供堅硬支持的 此處所使用的名詞"切片"是扑從 後可固定在玻璃栽片s戈其他支持^ : 4 # +切割,然 此處所使用々 的名詞,,染色’,是指以一右“、 色或螢光的物質As used herein, the noun "sentence S" mold, and a substance J two two fingers to infiltrate the tissue in a ~ 玉玉衣 (usually in the group, 'mox, sign, ^ to form a package block The embedding material therefore, in the 1 day material, then the hard character, and makes the cutting step easy to make the knife to provide hard support. The noun used here is "sliced" and can be fixed in the glass. Sgo other support ^ : 4 # + cutting, but the noun used here, dyed ', refers to a right ", color or fluorescent substance
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25360799A | 1999-02-19 | 1999-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWI252912B true TWI252912B (en) | 2006-04-11 |
Family
ID=22960971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW089102812A TWI252912B (en) | 1999-02-19 | 2000-02-18 | Histological processing of tissue and other material |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1155300A4 (en) |
| JP (1) | JP2002537554A (en) |
| CN (1) | CN1340156A (en) |
| AU (1) | AU2738100A (en) |
| HK (1) | HK1045189A1 (en) |
| TW (1) | TWI252912B (en) |
| WO (1) | WO2000049383A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1672028B (en) * | 2002-05-28 | 2011-12-28 | 戴尔帕斯有限公司 | Composition for the preparation of histological, autopsical, cytological samples |
| CN1816737B (en) * | 2003-06-30 | 2012-02-01 | 格罗宁根大学医学中心 | Method for histoprocessing |
| WO2007028202A1 (en) * | 2005-09-06 | 2007-03-15 | Leica Biosystems Melbourne Pty Ltd | Method and apparatus for handling tissue samples |
| FR2891052B1 (en) * | 2005-09-21 | 2007-12-21 | Histolex Soc Responsabilite Li | PROCESS FOR PREPARING A SAMPLE |
| CN105738182A (en) * | 2016-02-25 | 2016-07-06 | 河南中医学院 | Fluorescent staining method for observing plant microstructure |
| CN111610078B (en) * | 2020-07-03 | 2021-12-14 | 中国科学技术大学 | Biological tissue clearing reagent and biological tissue clearing method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960330A (en) * | 1985-07-16 | 1990-10-02 | Kerschmann Russell L | Image recording apparatus |
| EP0552013B1 (en) * | 1992-01-13 | 1999-04-07 | Hercules Incorporated | Thermally bondable fiber for high strength non-woven fabrics |
| US5858990A (en) * | 1997-03-04 | 1999-01-12 | St. Elizabeth's Medical Center | Fas ligand compositions for treatment of proliferative disorders |
-
2000
- 2000-01-26 AU AU27381/00A patent/AU2738100A/en not_active Abandoned
- 2000-01-26 HK HK02106739.1A patent/HK1045189A1/en unknown
- 2000-01-26 CN CN00803847A patent/CN1340156A/en active Pending
- 2000-01-26 WO PCT/US2000/001953 patent/WO2000049383A1/en not_active Ceased
- 2000-01-26 JP JP2000600075A patent/JP2002537554A/en not_active Withdrawn
- 2000-01-26 EP EP00905746A patent/EP1155300A4/en not_active Ceased
- 2000-02-18 TW TW089102812A patent/TWI252912B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000049383A1 (en) | 2000-08-24 |
| HK1045189A1 (en) | 2002-11-15 |
| JP2002537554A (en) | 2002-11-05 |
| EP1155300A1 (en) | 2001-11-21 |
| CN1340156A (en) | 2002-03-13 |
| AU2738100A (en) | 2000-09-04 |
| EP1155300A4 (en) | 2003-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Culling et al. | Cellular pathology technique | |
| Müller‐Reichert et al. | Cryoimmobilization and three‐dimensional visualization of C. elegans ultrastructure | |
| Blackstad | Electron microscopy of Golgi preparations for the study of neuronal relations | |
| CN108061677A (en) | For the fining agent and its purposes of biomaterial | |
| TW458767B (en) | Combined en bloc staining and embedding process | |
| TWI252912B (en) | Histological processing of tissue and other material | |
| US20170108414A1 (en) | High-resolution three-dimensional imaging of mammalian hearts | |
| Gerfen | Basic neuroanatomical methods | |
| JP2009229339A (en) | Sample preparation method for microscopic observation, and kit used for the same | |
| Seno et al. | Electron microscope observations on frozen-dried cells | |
| McClelland et al. | Effects of enhanced O2 transport on hepatocytes packed within a bioartificial liver device | |
| KR20170119936A (en) | A refractive index matching composition for biological tissue | |
| CN114279795A (en) | Rapid detection system, detection method and application of tissue sample | |
| Neves et al. | Micro‐shear bond strength of adhesives with different degrees of acidity: Effect on sound and artificially hypermineralized dentin | |
| JP2602789B2 (en) | A fat-soluble replacement agent for replacing a dehydrating agent for preparing a tissue sample and a method for preparing a tissue sample using the fat-soluble replacement agent | |
| Ushida et al. | Development of a method to preliminarily embed tissue samples using low melting temperature fish gelatin before sectioning: A technical note | |
| Yadav et al. | Improvised double-embedding technique of minute biopsies: a mega boon to histopathology laboratory | |
| Chaudhuri | Basic Histological Techniques (MicroTechniques) for Staining of Animal Tissue | |
| KR20070092200A (en) | Visualization formulations comprising Janus green shock and methods of visualization using the same | |
| Mahesh et al. | Plastination: an overview of the techniques and its application in pathologic tissue preservation | |
| Nagpal | Handbook Of Histopathology And Hematology Laboratory Techniques For MDS Oral Pathology Students | |
| TW463042B (en) | System for processing and imaging | |
| Taft | INTERCELLULAR SUBSTANCE OF THE CEREBRAL CORTEX (NISSL'S CEREBRAL GRAY MATTER): PHYSIOLOGIC SIGNIFICANCE | |
| Moss et al. | Techniques for thick-section Golgi impregnation of formalin-fixed brain tissue | |
| Burns | Preparation of thin epoxy resin sections from thick sections of paraffin-embedded material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |